Studies on experimental itch induced by kallikrein and bradykinin
Open Access
- 1 September 1974
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 54 (5) , 397-400
- https://doi.org/10.2340/0001555554397400
Abstract
Experimental itch, produced by intracutaneous injection of histamine, bradykinin and kallikrein, was compared in volunteer patients. The latent period until itch was perceived, the duration of the itch and the area of the flare response were measured. The effect of antihistamines on the itch and flare responses was studied. It was found that the latent period was not significantly shorter for bradykinin than for kallikrein, that itch induced by bradykinin, but not by kallikrein, was inhibited by the antihistamine levomepromazine, and that bradykinin induced a flare reaction which kallikrein did not. Bradykinin is not the main final mediator of kallikrein-induced itch. Kallikrein is an itch-producing proteolytic enzyme which does not release histamine from dermal mast cells.This publication has 4 references indexed in Scilit:
- Responses of skin blood vessels to bradykinin, histamine and 5‐hydroxytryptamineThe Journal of Physiology, 1967
- Studies on the mechanism of kinin formation in inflammationThe Journal of Physiology, 1967
- Proteolytic Activity in Development of Pain and ItchingJournal of Investigative Dermatology, 1960
- Pain‐producing substance in human inflammatory exudates and plasmaThe Journal of Physiology, 1957